Impella RP Flex with Smart Assist

Impella RP Flex Registry

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06637644

Enrollment

200

Registered

2024-10-15

Start date

2024-05-29

Completion date

2026-06-01

Last updated

2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Right Ventricular (RV) Dysfunction

Brief summary

To capture observational data of the Abiomed Impella RP Flex in a real-world setting.

Interventions

DEVICERight-sided ventricular assist device

Percutaneous device for right heart support

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Subjects who received mechanical circulatory support (MCS) with an Impella RP Flex will be considered eligible for the registry.

Exclusion criteria

* None

Design outcomes

Primary

Measure	Time frame	Description
Objectives	1 year post implant	Survival at hospital discharge, with follow-ups at 30 days, 90 days, and 1-year post-discharge of Impella RP patients from real-world surveillance data.

Countries

United States

Contacts

Primary ContactStacie Hallaway, Sr. Clinical Project Manager

shallawa@its.jnj.com839-216-3087

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026